Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Kidney Neoplasms × Sunitinib × Clear all

Phase

Phase 2 18 Phase NA 5 Phase 3 5 Phase 1 5 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 6 Breast Neoplasms 4 Sarcoma 2 Melanoma 2 Urinary Bladder Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumors Refractory to Standard Therapy 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Hemangioendothelioma 1 Gastrointestinal Stromal Tumors 1 Fatigue 1 Colorectal Neoplasms 1 Chondrosarcoma, Extraskeletal Myxoid 1 Chondrosarcoma 1 Breast Neoplasms, Male 1 Bone Neoplasms 1

Interventions

pembrolizumab 6 aldesleukin 6 Cyclophosphamide 5 fludarabine phosphate 4 fludarabine 4 Nivolumab 4 Sorafenib 3 Filgrastim 3 Everolimus 3 durvalumab 2 Temozolomide 2 Peripheral Blood Stem Cell Transplantation 2 Isotretinoin 2 Interleukin-2 2 Interferon-alpha 2 Fluorouracil 2 Dexamethasone 2 Bevacizumab 2 vorolanib 1 tremelimumab 1 tocilizumab 1 talazoparib 1 sargramostim 1 poly ICLC 1 palbociclib 1 oblimersen 1 isoquercitrin 1 entinostat 1 dactolisib 1 carfilzomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02446795 2017-01-18

QUASAR

Consorzio Oncotech

Phase 1/2 Unknown

Carcinoma, Renal Cell, Fatigue, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡